

          -  The subject was pregnant or lactating.

          -  The subject was a female at risk of pregnancy during the study and not taking adequate
             precautions against pregnancy.

          -  The subject had a known hypersensitivity to any of the test materials or related
             compounds.

          -  The subject was unable or unwilling to comply fully with the protocol.

          -  Treatment with investigational drug (s) within 6 months before the screening visit.

          -  The subject had previously entered in this study.

          -  Patient who planned to schedule elective surgery during the study

          -  The used of other antiviral agents
      